We’ll be at the Peptide Therapeutics Symposium in San Diego, October 20–21, 2026, with Yu (Roven) Wan attending on behalf of Pavonis.
We’ll be sharing research on how cyclic peptides bind to different receptors and how VICA™ helps compare those interactions. The work examines how changes to peptide sequences affect binding to PDGFRA and EGFR, supporting further investigation of peptide candidates.
If your team is comparing peptide candidates, we can discuss how binding measurements across different targets and experimental conditions could help you decide which candidates to study further. Bring your research questions so we can explore whether VICA could contribute to your work.
If you’re attending, we’d welcome a conversation about this work and our peptide research and radiobiology programs. Email todd@pavonis.ai to arrange a meeting.
View symposium details: https://peptidetherapeutics.org/symposium/